Global Opioid Induced Constipation Drugs Market Size, Status, Researches and Forecast 2017 To 2022

Posted on 2017-10-05 by Mark Hub in Healthcare // 0 Comments

MARKET RESEARCH HUB

Albany, US, 2017-Oct-05 — /EPR Network/ — A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Global Opioid Induced Constipation Drugs Market Forecast 2022”, which encloses important data about the global Opioid Induced Constipation Drugs market, analyzes and researches the Opioid Induced Constipation Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

Request For Free Sample Report: https://www.marketresearchhub.com/enquiry.php?type=S&repid=1336447

This report focuses on the top players in global market, like
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Opioid Induced Constipation Drugs can be split into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other

Market segment by Application, Opioid Induced Constipation Drugs can be split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Browse Full Report with TOC: https://www.marketresearchhub.com/report/global-opioid-induced-constipation-drugs-market-size-status-and-forecast-2022-report.html

Table of Content:

1 Industry Overview of Opioid Induced Constipation Drugs
1.1 Opioid Induced Constipation Drugs Market Overview
1.1.1 Opioid Induced Constipation Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Opioid Induced Constipation Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Opioid Induced Constipation Drugs Market by Type
1.3.1 Lubiprostone
1.3.2 Methyl Naltrexone Bromide
1.3.3 Naldemedine
1.3.4 Alvimopan
1.3.5 Other
1.4 Opioid Induced Constipation Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies

2 Global Opioid Induced Constipation Drugs Competition Analysis by Players
2.1 Opioid Induced Constipation Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Ironwood Pharmaceuticals Inc
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Daiichi Sankyo Co Ltd
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Pfizer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Progenics Pharmaceuticals Inc
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Shionogi & Co., Ltd
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Allergan Plc
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Nektar Therapeutics
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Purdue Pharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 S.L.A. Pharma AG
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Mundipharma International Limited
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Ono Pharmaceutical Co., Ltd
3.12 Takeda Pharmaceutical Company Limited
3.13 Theravance Biopharma Inc
3.14 Valeant Pharmaceuticals International
3.15 Cosmo Pharmaceuticals SA
3.16 Daewoong Pharmaceutical
3.17 C.B. Fleet Company
3.18 Sucampo Pharmaceuticals

4 Global Opioid Induced Constipation Drugs Market Size by Type and Application (2012-2017)
4.1 Global Opioid Induced Constipation Drugs Market Size by Type (2012-2017)
4.2 Global Opioid Induced Constipation Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Opioid Induced Constipation Drugs in Future
4.4 Top Consumer/End Users of Opioid Induced Constipation Drugs

Continue….

Enquire About This Report: https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1336447

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of Healthcare market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick